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Implication for health policy/practice/research/medical education:
In a study on 36 stable hemodialysis patients, we found a low serum 25-hydroxyvitamin D in diabetic male patients in comparison to non-
diabetic males. Further investigations need to define this aspect of hemodialysis patients.
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It is well found that the assessment of circulating 25-hydroxyvitamin D offers better information about 
vitamin D status in patients. This cross-sectional study was aimed to better understand the probable 
difference of 25-hydroxyvitamin D level in a group of hemodialysis (HD) patients with or without 
diabetes. 25-hydroxyvitamin D level (normal range of values is 25 to 125 nmol/L) was measured 
following an overnight fasting. The study was conducted on 36 subjects (15 female, 21 male), consisting 
of 25 (female=11, male=14) non-diabetic HD patients and 11 (female=4, male=7) diabetic HD patients. 
A significant difference of serum 25-hydroxyvitamin D level between diabetic and non-diabetic male 
HD  patients with more values of 25-hydroxyvitamin D level in none-diabetic HD patients was found 
(r=0.014). Least studied was conducted on the influence of diabetes on 25-hydroxyvitamin D level in 
HD patients, lower vitamin D level in diabetes patients may aggravates their  condition. Thus, further 
investigations need to define this aspect of hemodialysis patients.
Introduction
25-hydroxyvitamin D is the main circulating metabolite of 
vitamin D (1).  It is well found that the assessment of circulating 
25-hydroxyvitamin D offers better information vitamin D 
status in patients, while biological active form of vitamin D 
is 1,25(OH)2 vitamin D, synthesized in the kidney. Recently, 
various investigations have highlighted the role of plasma 
25-hydroxyvitamin D level in mineral metabolism dysregulation 
in chronic renal failure (1,2).  It has been established that 
a moderate reduction in plasma 25-hydroxyvitamin D 
level plays a role in the development of secondary form of 
hyperparathyroidism in patients under hemodialysis, while 
a greater reduction in plasma 25-hydroxyvitamin D level 
is associated with the risk of getting osteoporosis (1–3). 
Moreover, less attention has been made to 25-hydroxyvitamin 
D in hemodialysis patients with or without diabetes. This 
cross-sectional study was aimed to better understand the 
probable difference of 25-hydroxyvitamin D level in a group of 
hemodialysis patients with or without diabetes.
Patients and Methods
Patients
This cross-sectional study was carried out on a group of stable 
hemodialysis patients. According to the intensity of secondary 
hyperparathyroidism, each patient received oral active vitamin 
D3 (Calcitriol; Rocaltrol), calcium carbonate or Rena-Gel 
(Sevelamer) tablets at various doses. 
The study was done in the hemodialysis (HD) section of Hajar 
Medical Educational and Therapeutic Center of Shahrekord 
University of Medical Sciences in Shahrekord, Iran.
Laboratory methods
25-hydroxyvitamin D level (normal range of values is 25 to 
125 nmol/L) was measured following an overnight fasting, by 
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enzyme-linked immunosorbent assay (ELISA) method with 
DRG kits from Germany. Also serum pre-dialysis and post 
dialysis blood urea nitrogen (BUN) was measured. For the 
efficacy of HD, the urea reduction rate (URR) was calculated 
from pre- and post-blood urea nitrogen (BUN) data. Duration 
and proportion of hemodialysis were assessed from the patients’ 
records. The duration of each HD session was 4 hours.
Ethical issues
The research followed the tenets of the declaration of Helsinki; 
written informed consent was obtained and the research was 
approved by ethical committee of Shahrekord University of 
Medical Sciences.
Statistical analysis
Data were expressed as the mean±SD and median values. The 
comparison between the groups was done using the student’s 
t-test. The statistical analyses were performed using SPSS 11.5 
(SPSS Inc., Chicago, USA)). The statistical significance was 
determined at a p<0.05.
Results
The study was conducted on 36 (female 15, male 21), 
consisting of 25 (F=11, M=14) non-diabetic HD patients and 
11 (F=4, M=7) diabetic HD patients. Table 1 summarizes 
some data of the patients. The mean patients’ age was 47±17 
years. The mean value of serum 25-hydroxyvitamin D level 
of patients was 10.5±18.7 nmol/L. There were no significant 
differences of serum 25-hydroxyvitamin D level between male 
and female subjects or diabetic and non-diabetic patients (p; 
N.S). A significant difference of serum 25-hydroxyvitamin D 
level between diabetic and non-diabetic subjects of male HD 
patients with more values of 25-hydroxyvitamin D level in 
none-diabetic HD patients was found (r=0.014). 
undergoing HD and found that 97% of the patients had vitamin 
D levels in the suboptimal range (4). In a study on 230 patients, 
Wang et al. found that a lower serum 25-hydroxyvitamin D level 
was associated with an increased risk of cardiovascular events 
in routine peritoneal dialysis patients (5). Limited studies have 
conducted on the impact of diabetes on 25-hydroxyvitamin D 
level in HD patients. Lower vitamin D level in diabetic patients 
may aggravate their conditions. 
Conclusion
In summary, we concluded that our findings are of interest 
for two reasons: first, because there is limited previous data 
concerning low serum 25-hydroxyvitamin D in diabetics 
in comparison to non-diabetic patients. However further 
investigations are needed to define this aspect of hemodialysis 
patients.
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Table 1.  Data of hemodialysis patients
Total patients N=36 Mean ±SD Median
Age (years) 47±17 43
DH* (months) 32±36 19
Dialysis proportion 123±54 156
URR (%) 59±9 57.5
25-OH vit. D (nmol/l) 10.5±18.7 3.5
*Duration of hemodialysis
Discussion
In this study we found a significant difference of serum 
25-hydroxyvitamin D level between diabetic and non-
diabetic subjects of male HD patients with more values of 
25-hydroxyvitamin D level in none-diabetic HD patients 
was found. Gonzalez et al. conducted a study on 103 patients 
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